Literature DB >> 18973730

Pragmatic consideration of recent randomized, placebo-controlled clinical trials for treatment of fibromyalgia.

Andrew J Holman1.   

Abstract

A flurry of recent randomized, placebo-controlled trials assessing dissimilar pharmacotherapeutic treatment options for fibromyalgia (FM) have been presented in the past few years. This review evaluates these trials in light of recent pathophysiological concepts germane to FM, including mood disorders, autonomic dysregulation, altered sleep stage architecture, and the diagnostic tender point controversy. Studies with gabapentin, pregabalin, duloxetine, milnacipran, sodium oxybate, and pramipexole for treatment of FM are discussed.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18973730     DOI： 10.1007/s11916-008-0067-5

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN： 1534-3081


  34 in total

1.  Dysautonomia among patients with fibromyalgia: a noninvasive assessment.

Authors:  S R Raj; D Brouillard; C S Simpson; W M Hopman; H Abdollah
Journal:  J Rheumatol       Date:  2000-11       Impact factor: 4.666

2.  A Lecture on Lumbago: Its Lessons and Analogues: Delivered at the National Hospital for the Paralysed and Epileptic.

Authors:  W R Gowers
Journal:  Br Med J       Date:  1904-01-16

Review 3.  Fibromyalgia: a rheumatologic diagnosis?

Authors:  Gerhard K M Endresen
Journal:  Rheumatol Int       Date:  2007-07-20       Impact factor: 2.631

4.  A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.

Authors:  Lesley M Arnold; Amy Rosen; Yili Lu Pritchett; Deborah N D'Souza; David J Goldstein; Smriti Iyengar; Joachim F Wernicke
Journal:  Pain       Date:  2005-11-17       Impact factor: 6.961

5.  A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.

Authors:  Andrew J Holman; Robin R Myers
Journal:  Arthritis Rheum       Date:  2005-08

Review 6.  The mechanism of action of gabapentin in neuropathic pain.

Authors:  J Kenneth Baillie; Ian Power
Journal:  Curr Opin Investig Drugs       Date:  2006-01

Review 7.  EULAR evidence-based recommendations for the management of fibromyalgia syndrome.

Authors:  S F Carville; L Arendt-Nielsen; S Arendt-Nielsen; H Bliddal; F Blotman; J C Branco; D Buskila; J A P Da Silva; B Danneskiold-Samsøe; F Dincer; C Henriksson; K G Henriksson; E Kosek; K Longley; G M McCarthy; S Perrot; M Puszczewicz; P Sarzi-Puttini; A Silman; M Späth; E H Choy
Journal:  Ann Rheum Dis       Date:  2007-07-20       Impact factor: 19.103

Review 8.  Sleep in fibromyalgia patients: subjective and objective findings.

Authors:  S M Harding
Journal:  Am J Med Sci       Date:  1998-06       Impact factor: 2.378

9.  Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial.

Authors:  Jon I Russell; Philip J Mease; Timothy R Smith; Daniel K Kajdasz; Madelaine M Wohlreich; Michael J Detke; Daniel J Walker; Amy S Chappell; Lesley M Arnold
Journal:  Pain       Date:  2008-04-18       Impact factor: 6.961

Review 10.  History of fibromyalgia: past to present.

Authors:  Fatma Inanici; Muhammad B Yunus
Journal:  Curr Pain Headache Rep       Date:  2004-10
View more
  2 in total

1.  Fibromyalgia and myofascial pain syndrome-a dilemma.

Authors:  H C Chandola; Arunangshu Chakraborty
Journal:  Indian J Anaesth       Date:  2009-10

2.  Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment.

Authors:  Enrico Bellato; Eleonora Marini; Filippo Castoldi; Nicola Barbasetti; Lorenzo Mattei; Davide Edoardo Bonasia; Davide Blonna
Journal:  Pain Res Treat       Date:  2012-11-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.